Centrosome Amplification in Human Breast Cancer

人类乳腺癌中心体扩增

• 批准号: 6542155
• 负责人: JEFFREY L SALISBURY
• 金额: $ 27.17万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-01-01 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6542155
• 关键词: aneuploidy; biological signal transduction; breast neoplasms; carcinogenesis; cell cycle; cell cycle proteins; centrosome; chromosome movement; electron microscopy; estrogens; flow cytometry; fluorescent in situ hybridization; growth factor receptors; high performance liquid chromatography; human tissue; immunocytochemistry; mammary epithelium; microtubules; mitotic spindle apparatus; neoplastic growth; phosphorylation; tissue /cell culture; western blottings

DESCRIPTION (provided by applicant): Cells of malignant breast tumors exhibit centrosome defects including an excess number of centrioles, increased microtubule nucleation capacity, and inappropriate phosphorylation of centrosomal proteins, a condition termed 'centrosome amplification Centrosome amplification leads to multipolar mitosis and consequent chromosomal instability, and therefore, is one mechanism by which aneuploidy and phenotypic variability arise in the development of cancer. We propose that centrosome amplification is an early event in the development of breast cancer, and that amplified centrosomes may arise through one of several alternative mechanisms. We propose to characterize the origin of centrosome amplification during the development of breast tumors. We will test the hypothesis that ER and growth factor signaling are mechanistically coupled to centriole separation and centrosome duplication. And finally, we will experimentally disrupt cell cycle progression in normal breast and tumor-derived cell lines to test the hypothesis that the G 1/S and G2/M cell cycle checkpoints are mechanistically coupled to centrosome duplication and that this linkage becomes uncoupled during mammary tumorigenesis. The study of centrosome behavior is of fundamental importance to our understanding of the origin of malignant tumors and may reveal new targets for intervention or prevention of the development of breast cancer.

描述（由申请人提供）：恶性乳腺肿瘤细胞表现出中心体缺陷，包括中心粒数量过多，微管成核能力增加，中心体蛋白不适当磷酸化，这种情况被称为“中心体扩增”。中心体扩增导致多极有丝分裂和随之而来的染色体不稳定，因此，是非整倍体和表型变异在癌症发展中出现的一种机制。我们提出中心体扩增是乳腺癌发展的早期事件，并且中心体扩增可能通过几种替代机制之一产生。我们建议描述在乳腺肿瘤发展过程中中心体扩增的起源。我们将检验内质网和生长因子信号传导机制耦合于中心粒分离和中心体复制的假设。最后，我们将通过实验破坏正常乳腺和肿瘤衍生细胞系的细胞周期进程，以验证g1 /S和G2/M细胞周期检查点与中心体复制机制耦合的假设，并且这种连接在乳腺肿瘤发生过程中被解除耦合。中心体行为的研究对我们了解恶性肿瘤的起源具有重要意义，并可能揭示干预或预防乳腺癌发展的新靶点。